Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Developed a bioresorbable polymer stent designed to promote natural arterial remodeling post angioplasty. Achieved CE Mark clearance for its next-generation device in 2015. In vivo and in vitro data demonstrated the scaffold’s ability to dismantle over an optimized time horizon and support natural healing without permanent metallic implants. The company reported positive preclinical and clinical results prior to acquisition by Terumo. As of acquisition date (2014), the company had reached significant clinical milestones but was not yet commercial. No recent updates post-acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arterial Remodeling Technologies.